You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (292)

Journals (0)

1-10 of 292 results for hormone receptor-negative breast cancer

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease

Open access

Review article

First published 2018

CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease

Adriana Matutino, Carla Amaro, Sunil Verma

Therapeutic Advances in Medical Oncology

Select article: Gonadotropin-releasing hormone receptor inhibits triple-negative breast cancer proliferation and metastasis

Open access

Research article

First published 2022-3

Gonadotropin-releasing hormone receptor inhibits triple-negative breast cancer proliferation and metastasis

Cai-Ping Chen, Xiang Lu

Journal of International Medical Research

Select article: Relationship between endocrine resistance and the periods of adjuvant endocrine treatment for hormone receptor-positive,HER2-negative breast cancer

Free access

Research article

First published 2021-11-05

Relationship between endocrine resistance and the periods of adjuvant endocrine treatment for hormone receptor-positive,HER2-negative breast cancer

Jun Yamamura, Yukiko Miyamura, Shunji Kamigaki [...]

Breast Disease

Select article: Comparison of Safety and Treatment Continuity of Palbociclib and Abemaciclib for Hormone Receptor-Positive,HER2-Negative Metastatic/Recurrent Breast Cancer

Retricted access

Research article

First published 2024-12

Comparison of Safety and Treatment Continuity of Palbociclib and Abemaciclib for Hormone Receptor-Positive,HER2-Negative Metastatic/Recurrent Breast Cancer

Makiko Go, Michio Kimura, Shiori Yamada [...]

Journal of Pharmacy Practice

Select article: Hormone Receptor Positive/HER2 Negative Breast Cancer With Isolated Bladder Metastasis: A Rare Case

Open access

Case report

First published 2021

Hormone Receptor Positive/HER2 Negative Breast Cancer With Isolated Bladder Metastasis: A Rare Case

Noman Ahmed Jang Khan, Mahmoud Abdallah, Maria Tria Tirona

Journal of Investigative Medicine High Impact Case Reports

Select article: The introduction of a third CDK4/6 inhibitor does not change the cost-effectiveness profile in first and subsequent-lines after progression or relapse during previous endocrine therapy in patients with hormone receptor positive (HR+)/human epidermal receptor-2 negative (HER-2) advanced or metastatic breast cancer

Retricted access

Article commentary

First published 2020-9

The introduction of a third CDK4/6 inhibitor does not change the cost-effectiveness profile in first and subsequent-lines after progression or relapse during previous endocrine therapy in patients with hormone receptor positive (HR+)/human epidermal receptor-2 negative (HER-2) advanced or metastatic breast cancer

Jacopo Giuliani, Andrea Bonetti

Journal of Oncology Pharmacy Practice

Select article: The impact of HER2 low positivity in hormone receptor-positive,HER2-negative breast cancer treated with neoadjuvant chemotherapy

Open access

Research article

First published 2026

The impact of HER2 low positivity in hormone receptor-positive,HER2-negative breast cancer treated with neoadjuvant chemotherapy

Mustafa Ersoy

Cancer Biomarkers

Select article: Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive,Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Open access

Review article

First published 2015

Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive,Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Adam M. Brufsky

Clinical Medicine Insights: Oncology

Select article: Impact of low hormone receptor expression on neoadjuvant chemotherapy response and patterns of care in non-metastatic HER2-negative breast cancer: a US National Cancer Database analysis

Open access

Research article

First published 2025

Impact of low hormone receptor expression on neoadjuvant chemotherapy response and patterns of care in non-metastatic HER2-negative breast cancer: a US National Cancer Database analysis

Dionisia Quiroga, Charles Pei, Julie A. Stephens [...]

Therapeutic Advances in Medical Oncology

Select article: Olaparib in hormone receptor-positive,HER2-negative metastatic breast cancer with a somatic BRCA2 mutation

Open access

Case report

First published 2021

Olaparib in hormone receptor-positive,HER2-negative metastatic breast cancer with a somatic BRCA2 mutation

Lee S. Schwartzberg, Lesli A. Kiedrowski

Therapeutic Advances in Medical Oncology

1
2
3
•••
30
10 / page

Article type

Publication date

Subjects

Access